文献速递认知障碍与痴呆

界定淀粉样蛋白PET预测未来认知下降与淀粉样蛋白累积的最低阈值

Defining the Lowest Threshold for Amyloid-PET to Predict Future Cognitive Decline and Amyloid Accumulation.
PubMed 文献 · Neurology · 2020-11-16

研究在三个独立临床正常个体样本中,基于基线分布最低点重新定义β-淀粉样蛋白(Aβ)PET阈值,该阈值可稳健预测未来Aβ累积和认知下降。序贯Aβ截断值测试显示,不同样本中由未来Aβ-PET累积和PACC下降推导的截断值汇聚于同一拐点,最优截断值落在Centiloid 15-18.5的短范围内。

要点

  • 临床正常个体中Aβ-PET最优截断值范围为Centiloid 15-18.5。
  • 截断值收敛提示Aβ与认知可能同期出现早期变化。
  • 优化阈值可指导针对早期Aβ的研究和临床试验。

核心结论

  • 在临床正常个体中,基于基线分布最低点重新定义的Aβ-PET阈值可稳健预测未来Aβ累积和认知下降。

研究设计与样本

  • 研究纳入三个独立样本的临床正常参与者:哈佛老龄脑研究(n=342)、澳大利亚衰老影像、生物标志物与生活方式研究(n=157)和阿尔茨海默病神经影像倡议(n=356),测试序贯Aβ截断值。

主要发现

  • 各样本内由未来Aβ-PET累积和PACC下降推导的截断值汇聚于同一拐点,超过该拐点后轨迹偏离正常。
  • 跨样本最优截断值落在Centiloid 15-18.5的短范围内。

关键数值与推荐

  • 最优Aβ-PET截断值范围为Centiloid 15-18.5,对应临床正常个体未来Aβ累积和认知下降的预测。

临床怎么用

  • 优化阈值可帮助指导针对早期Aβ的未来研究和临床试验。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: As clinical trials move toward earlier intervention, we sought to redefine the β-amyloid (Aβ)-PET threshold based on the lowest point in a baseline distribution that robustly predicts future Aβ accumulation and cognitive decline in 3 independent samples of clinically normal individuals. METHODS: Sequential Aβ cutoffs were tested to identify the lowest cutoff associated with future change in cognition (Preclinical Alzheimer Cognitive Composite [PACC]) and Aβ-PET in clinically normal participants from the Harvard Aging Brain Study (n = 342), Australian Imaging, Biomarker and Lifestyle study of aging (n = 157), and Alzheimer's Disease Neuroimaging Initiative (n = 356). RESULTS: Within samples, cutoffs derived from future Aβ-PET accumulation and PACC decline converged on the same inflection point, beyond which trajectories diverged from normal. Across samples, optimal cutoffs fell within a short range (Centiloid 15-18.5). DISCUSSION: These optimized thresholds can help to inform future research and clinical trials targeting early Aβ. Threshold convergence raises the possibility of contemporaneous early changes in Aβ and cognition. CLASSIFICATION OF EVIDENCE: This study provides Class II evidence that among clinically normal individuals a specific Aβ-PET threshold is predictive of cognitive decline.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Farrell ME, Jiang S, Schultz AP, et al. Defining the Lowest Threshold for Amyloid-PET to Predict Future Cognitive Decline and Amyloid Accumulation. Neurology. 2020. PMID: 33199430. doi:10.1212/WNL.0000000000011214

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。